Ihuman Price To Sales Ratio from 2010 to 2024

IH Stock  USD 1.55  0.09  5.49%   
Ihuman's Price To Sales Ratio is decreasing with slightly volatile movements from year to year. Price To Sales Ratio is predicted to flatten to 1.14. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Ihuman's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
1.19611203
Current Value
1.14
Quarterly Volatility
16.86814489
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ihuman financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ihuman's main balance sheet or income statement drivers, such as Tax Provision of 34.8 M, Depreciation And Amortization of 6 M or Interest Expense of 13.1 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0117 or PTB Ratio of 1.34. Ihuman financial statements analysis is a perfect complement when working with Ihuman Valuation or Volatility modules.
  
Check out the analysis of Ihuman Correlation against competitors.

Latest Ihuman's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Ihuman Inc over the last few years. Price to Sales Ratio is figured by comparing Ihuman Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Ihuman sales, a figure that is much harder to manipulate than other Ihuman Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Ihuman's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ihuman's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.09 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Ihuman Price To Sales Ratio Regression Statistics

Arithmetic Mean25.16
Geometric Mean12.94
Coefficient Of Variation67.05
Mean Deviation15.13
Median37.77
Standard Deviation16.87
Sample Variance284.53
Range36.799
R-Value(0.87)
Mean Square Error74.17
R-Squared0.76
Significance0.000024
Slope(3.28)
Total Sum of Squares3,983

Ihuman Price To Sales Ratio History

2024 1.14
2023 1.2
2022 0.97
2021 1.0
2020 10.06
2019 23.06

About Ihuman Financial Statements

Investors use fundamental indicators, such as Ihuman's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Ihuman's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Price To Sales Ratio 1.20  1.14 

Currently Active Assets on Macroaxis

Check out the analysis of Ihuman Correlation against competitors.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Earnings Share
(0.16)
Revenue Per Share
18.263
Quarterly Revenue Growth
(0.11)
Return On Assets
0.0456
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.